Latest Impairment News

Collins Foods delivered record $1.5 billion revenue in FY25, pivoting to focus on KFC growth in Australia and Germany while exiting Taco Bell. Despite impairments and wage remediation costs, the company targets strong profit growth in FY26.

Clime Investment Management has reported a strong FY25 profit turnaround, posting $2.1 million pretax and amortisation profit and declaring a fully franked dividend. The company outlines ambitious growth and margin targets for FY26 amid strategic restructuring and technology investments.

Mayfield Childcare Limited reported a modest underlying EBITDA loss for the first half of 2025 amid occupancy challenges and acquisition underperformance. The company’s operational overhaul and targeted investments signal a cautious but hopeful recovery trajectory.

Halo Technologies Holdings Ltd reported a $6.06 million half-year loss, narrowing from last year’s $8.04 million, while preparing an $11 million rights issue to bolster its finances amid auditor concerns over asset valuations.

FirstWave Cloud Technology reports a significant reduction in losses for FY25, driven by operational restructuring and new AI initiatives, while setting sights on Latin American expansion.

Mayfield Childcare Limited reported a 14.9% revenue increase to $43.9 million for the half-year ended June 2025, but underlying earnings fell short due to occupancy struggles and underperforming acquisitions. The company faces a significant goodwill impairment and is focused on operational recovery.

TerraCom Limited reported a statutory loss of A$33.7 million for FY2025 amid lower coal sales and prices, while progressing its Moorlands Thermal Coal Project in partnership with Wintime Energy Group.

TasFoods reports a $3.6 million net loss for H1 2025, impacted by oversupply and discounted poultry prices, while advancing key initiatives including pet treats expansion and planned divestments.

Argent BioPharma reported a net loss of A$17.84 million for FY2025, reflecting a strategic pivot towards core drug development and clinical advancement. The company secured key EU approvals and raised significant capital to support its neuro-immune modulatory pipeline.

5G Networks Limited (5GN) reported a robust 27% revenue increase in FY25, driven by organic growth and a strategic acquisition of an 89.65% stake in cybersecurity firm AUCyber. The company’s underlying EBITDA turned positive, signaling a financial turnaround despite integration costs.

Spenda Limited reported a 106% surge in revenue to $11.1 million for FY25, driven by acquisitions and expanded services, yet posted a substantial $24.3 million net loss largely due to goodwill impairment. The company’s strategic moves and funding needs highlight a pivotal phase ahead.

Elanor Investors Group reported a substantial $157.8 million net loss for FY24 amid asset devaluations and debt covenant breaches, prompting a strategic recapitalisation and leadership transition.